ARTICLE
4 October 2023

Holland & Knight Health Dose: October 3, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: Last-Minute Agreement Saves Government Shutdown (Temporarily)
  • Senate Committee on HELP RFIs on CDC, NIH
  • Wyden, Pallone to Investigate Medicaid MCOs' Use of Prior Authorization
  • Senate Finance Leaders Introduce PBM Bill
  • Rep. Kim to Challenge Menendez for New Jersey Seat
  • Ways & Means Advances HSA Legislation
  • ARPA-H Announces Launch of ARPANET-H
  • Biden Administration to Begin Enforcement of Drug Price Reporting Requirements
  • Medicare Drug Price Negotiations to Proceed
  • CBO Issues Report on CMMI

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More